 |
The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.
Every medication approved by the FDA has benefits as well as risks. It’s important that patients hear both and have a clear understanding so they can make informed decisions with their health care professional. Benefit and risk information in clinical trials, Medication Guides, and drug advertisements are reviewed.
The pharmacists in FDA's Center for Drug Evaluation and Research (CDER), Office of Communications (OCOMM), Division of Drug Information (DDI) prepared an online video which talks about the benefit risk balance and how health care professionals may approach this topic with their patients. This video is part of FDA Drug Info Rounds, a series of training videos for practicing clinical and community pharmacists.
To watch this video, please visit: Communicating Benefit and Risk Information.
All videos are available at: FDA Drug Info Rounds.
This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO FDA (1-888-463-6332) or (301) 796-3400 from 8:00 am - 4:30 pm Monday - Friday. You can also email us at druginfo@fda.hhs.gov.
- For additional drug information, please visit the DDI Web page.
- For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info
- This service is provided to you at no charge by the U.S. Food & Drug Administration (FDA).
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
